» Articles » PMID: 37514002

Indole Antitumor Agents in Nanotechnology Formulations: An Overview

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2023 Jul 29
PMID 37514002
Authors
Affiliations
Soon will be listed here.
Abstract

The indole heterocycle represents one of the most important scaffolds in medicinal chemistry and is shared among a number of drugs clinically used in different therapeutic areas. Due to its varied biological activities, high unique chemical properties and significant pharmacological behaviors, indole derivatives have drawn considerable interest in the last decade as antitumor agents active against different types of cancers. The research of novel antiproliferative drugs endowed with enhanced efficacy and reduced toxicity led to the approval by U.S. Food and Drug Administration of the indole-based anticancer agents Sunitinib, Nintedanib, Osimertinib, Panobinostat, Alectinib and Anlotinib. Additionally, new drug delivery systems have been developed to protect the active principle from degradation and to direct the drug to the specific site for clinical use, thus reducing its toxicity. In the present work is an updated review of the recently approved indole-based anti-cancer agents and the nanotechnology systems developed for their delivery.

Citing Articles

Bisindole Compounds-Synthesis and Medicinal Properties.

Marinescu M Antibiotics (Basel). 2025; 13(12.

PMID: 39766602 PMC: 11727274. DOI: 10.3390/antibiotics13121212.


Antitumor activity of anlotinib in malignant melanoma: modulation of angiogenesis and vasculogenic mimicry.

Yang Q, Li Q, Fan H Arch Dermatol Res. 2024; 316(7):447.

PMID: 38958761 DOI: 10.1007/s00403-024-03020-1.

References
1.
Navid F, Christensen R, Minkin P, Stewart C, Furman W, Baker S . Stability of sunitinib in oral suspension. Ann Pharmacother. 2008; 42(7):962-6. DOI: 10.1345/aph.1K654. View

2.
Zha Q, Zhang L, Guo Y, Bao R, Shi F, Shi Y . Preparation and Study of Folate Modified Albumin Targeting Microspheres. J Oncol. 2022; 2022:3968403. PMC: 8816550. DOI: 10.1155/2022/3968403. View

3.
Ahmad A, Sakr W, Rahman K . Anticancer properties of indole compounds: mechanism of apoptosis induction and role in chemotherapy. Curr Drug Targets. 2010; 11(6):652-66. DOI: 10.2174/138945010791170923. View

4.
Braatz D, Dimde M, Ma G, Zhong Y, Tully M, Grotzinger C . Toolbox of Biodegradable Dendritic (Poly glycerol sulfate)-SS-poly(ester) Micelles for Cancer Treatment: Stability, Drug Release, and Tumor Targeting. Biomacromolecules. 2021; 22(6):2625-2640. DOI: 10.1021/acs.biomac.1c00333. View

5.
Xu Y, Liu Y, He T, Zhang Y, Wang M, Yuan H . Biguanides decorated albumin nanoparticles loading nintedanib for synergic enhanced hepatocellular carcinoma therapy. Colloids Surf B Biointerfaces. 2021; 207:112020. DOI: 10.1016/j.colsurfb.2021.112020. View